Evidence map›Paper›PMID 29423035›Full record

ArticleOncotarget2018

Yuan Zhou, Jing Huang, Xi Yu, Xin Jiang, Yaoyao Shi, Yuanyuan Weng, Yue Kuai, Lizhen Lei, Guoping Ren, Xiaowen Feng and 6 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncotarget, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 1 country.

Yuan ZhouDepartment of Hepatopancreatobiliary Surgery, Ningbo Medical Center Lihuili Eastern Hospital, Ningbo, China.
Jing HuangDepartment of Hepatopancreatobiliary Surgery, Ningbo Medical Center Lihuili Eastern Hospital, Ningbo, China.
Xi YuDepartment of Hepatopancreatobiliary Surgery, Ningbo Medical Center Lihuili Eastern Hospital, Ningbo, China.
Xin JiangDepartment of Pathology and Pathophysiology, Institute of Pathology and Forensic Medicine, Zhejiang University School of Medicine, Hangzhou, China.
Yaoyao ShiDepartment of Pathology and Pathophysiology, Institute of Pathology and Forensic Medicine, Zhejiang University School of Medicine, Hangzhou, China.
Yuanyuan WengDepartment of Pathology and Pathophysiology, Institute of Pathology and Forensic Medicine, Zhejiang University School of Medicine, Hangzhou, China.
Yue KuaiDepartment of Pathology and Pathophysiology, Institute of Pathology and Forensic Medicine, Zhejiang University School of Medicine, Hangzhou, China.
Lizhen LeiDepartment of Pathology and Pathophysiology, Institute of Pathology and Forensic Medicine, Zhejiang University School of Medicine, Hangzhou, China.
Guoping RenThe First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Xiaowen FengThe First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Guoping ZhongDivision of Pathology, Yinzhou Hospital Affiliated to Medical School of Ningbo University, Ningbo, China.
Qingmeng LiuDivision of Pathology, The Second People's Hospital, Shaoxing, China.
Hongyang PanEpitomics (Hangzhou) Inc., Hangzhou, Zhejiang, P.R. China.
Xinxia ZhangEpitomics (Hangzhou) Inc., Hangzhou, Zhejiang, P.R. China.
Ren ZhouDepartment of Pathology and Pathophysiology, Institute of Pathology and Forensic Medicine, Zhejiang University School of Medicine, Hangzhou, China.
Caide LuDepartment of Hepatopancreatobiliary Surgery, Ningbo Medical Center Lihuili Eastern Hospital, Ningbo, China.
Ningbo Medical Center Lihuili Hospital · CNZhejiang University · CNFirst Affiliated Hospital Zhejiang University · CNNingbo University · CNShaoxing Second Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Early diagnosis of pancreatic cancer, one of the most deadly cancers with low survival rates, is difficult, and effective biomarkers are urgently needed. Lipopolysaccharide-induced tumor necrosis factor-α factor (

Indexed as

lipopolysaccharide-induced tumor necrosis factor-α factor (LITAF)pancreatic cancerpromoter methylationtumor suppressor gene

Identifiers

PMID29423035
PMCPMC5790452
OpenAlexW2776148044

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.